Sie befinden sind hier: Startseite > Börse > Unternehmensnachrichten > Keymed China New York

Keymed, Biosciences

Keymed China New York

27.08.2025 - 08:17:47

Keymed Biosciences Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum

View original content:https://www.prnewswire.co.uk/news-releases/keymed-biosciences-02162hk-reports-strong-interim-2025-results-with-accelerated-commercialization-and-robust-rd-momentum-302539775.html

@ prnewswire.co.uk